12:00 AM
Jun 04, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Azithromycin: Postmarketing study data

Vanderbilt University School of Medicine, Nashville, Tenn.
Product: Azithromycin
Business: Infectious
Molecular target: Ribosomal 50S subunit
Description: Macrolide antibiotic
Indication: Treat bacterial infection
Endpoint: Risk of cardiovascular death; death from any cause
Status: Postmarketing study data

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >